Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
45 studies found for:    Open Studies | "Oropharyngeal Neoplasms"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Oropharyngeal Neoplasms" (45 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting A Study of Mucosal Sparing Proton Beam Therapy (PBT) in Resected Oropharyngeal Tumors
Condition: Oropharyngeal Tumor
2 Unknown  Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.
Condition: Oropharyngeal Neoplasms
Intervention: Drug: Cetuximab
3 Recruiting Dose Escalation Versus Standard in Laryngopharyngeal Cancers
Conditions: Malignant Neoplasm of Oropharynx Stage III;   Malignant Neoplasm of Larynx Stage III;   Malignant Neoplasm of Hypopharynx Stage III;   Malignant Neoplasm of Oropharynx Stage IVa;   Malignant Neoplasm of Oropharynx Stage IVb;   Malignant Neoplasm of Larynx Stage IV;   Malignant Neoplasm of Hypopharynx Stage IVa;   Malignant Neoplasm of Hypopharynx Stage IVb
Interventions: Radiation: Escalated Dose;   Radiation: Standard Dose
4 Not yet recruiting ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Treatment
Conditions: Oral Cavity Neoplasm;   Oropharyngeal Neoplasm;   Stage I Oral Cavity Squamous Cell Carcinoma;   Stage I Oropharyngeal Squamous Cell Carcinoma;   Stage II Oral Cavity Squamous Cell Carcinoma;   Stage II Oropharyngeal Squamous Cell Carcinoma;   Stage III Oral Cavity Squamous Cell Carcinoma;   Stage III Oropharyngeal Squamous Cell Carcinoma;   Stage IVA Oral Cavity Squamous Cell Carcinoma;   Stage IVA Oropharyngeal Squamous Cell Carcinoma;   Stage IVB Oral Cavity Squamous Cell Carcinoma;   Stage IVB Oropharyngeal Squamous Cell Carcinoma;   Stage IVC Oral Cavity Squamous Cell Carcinoma;   Stage IVC Oropharyngeal Squamous Cell Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Metformide Hydrochloride/Pioglitazone Hydrochloride Extended-Release Tablet;   Other: Pharmacological Study;   Other: Placebo
5 Recruiting A Pilot Study Assessing Robotic Surgery in the Seated Position for Benign and Malignant Lesions of the Head and Neck
Conditions: Oropharyngeal Neoplasms;   Head and Neck Cancer
Intervention: Device: Transoral Robotic Surgery (TORS) with the daVinci Robotic Surgical System device
6 Not yet recruiting Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell Carcinoma
Conditions: Carcinoma, Squamous;   Squamous Cell Carcinoma;   Oropharyngeal Neoplasms;   Oropharyngeal Cancer
Interventions: Drug: cisplatin;   Drug: Cetuximab;   Drug: BYL719
7 Recruiting De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study
Conditions: Carcinoma, Squamous Cell;   Head and Neck Neoplasms;   Oropharyngeal Neoplasms
Interventions: Radiation: Intensity Modulated Radiotherapy (IMRT);   Drug: Cisplatin (or alternative);   Procedure: Assessment for surgical evaluation
8 Unknown  Analgesia of Fibula Free Flap Donor Site by Peri-Neuronal Catheter in Oro-Pharyngeal Carcinoma Surgery
Condition: Oropharyngeal Neoplasms
Intervention: Device: Peri-Neuronal Catheter
9 Recruiting Quarterback 2 - Sequential Therapy With Reduced Dose Chemoradiotherapy for HPV Oropharynx Cancer
Condition: Locally Advanced HPV Positive Oropharynx Cancer
Interventions: Radiation: PTV56;   Radiation: PTV50.4
10 Not yet recruiting Impact of HPV Vaccine On The Prevalence Of HPV In Norway
Conditions: Cervical Intraepithelial Neoplasia;   Cervical Cancer;   Oropharyngeal Cancer
Interventions: Procedure: Self sample from vagina;   Procedure: Self sample from the oral cavity;   Other: Questionnaire
11 Recruiting Evaluation of De-escalated Adjuvant Radiation Therapy for Human Papillomavirus (HPV)-Associated Oropharynx Cancer
Condition: Oropharynx Cancer
Interventions: Radiation: Adjuvant Radiation Therapy;   Drug: Docetaxel;   Drug: Cisplatin
12 Recruiting E7 TCR T Cells With or Without PD-1 Blockade for Human Papillomavirus-Associated Cancers
Conditions: Cervical Cancer;   Vaginal Cancer;   Anal Cancer;   Penile Cancer;   Oropharyngeal Cancer
Interventions: Biological: E7 TCR cells;   Drug: pembrolizumab;   Drug: aldesleukin;   Drug: fludarabine;   Drug: cyclophosphamide
13 Recruiting Image-Guided Stereotactic Radiosurgery (SRS) Boost for HPV-Oropharyngeal Cancer
Condition: Cancer of the Oropharynx
Intervention: Radiation: Stereotactic Radiosurgery
14 Recruiting Cardiopulmonary Fitness in Long-Term Survivors of HPV-related Oropharynx Cancers
Condition: Oropharynx Cancers
Interventions: Other: blood draw;   Behavioral: study questionnaire;   Other: cardiopulmonary exercise testing (CPET);   Other: DXA (dual-energy x-ray absorptiometry) scan
15 Recruiting Swallowing, Speech and Quality of Life of Patients With Carcinoma of the Oropharynx
Condition: Squamous Cell Carcinoma of the Oropharynx
Intervention: Procedure: Ability to swallow, speak and quality of life
16 Recruiting Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients
Conditions: Oral Cavity Cancer;   Oropharyngeal Cancer;   Lymphedema;   Fibrosis
Interventions: Other: LEF measures;   Procedure: Technical measure
17 Recruiting Improving Trans-oral Surgical Outcomes Through Intra-operative Image Guidance
Condition: Oropharyngeal Cancer
Intervention: Other: Intraoperative CT imaging
18 Recruiting HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA
Conditions: Human Papillomavirus-Related Carcinoma;   Human Papillomavirus Positive Oropharyngeal Carcinoma;   Human Papillomavirus Positive Cervical Carcinoma;   Human Papillomavirus Positive Anal Carcinoma;   Human Papillomavirus Positive Vulvar Carcinoma;   Human Papillomavirus Positive Penile Carcinoma
Intervention: Genetic: HPV Specific T Cells
19 Recruiting NBI to Characterize Patterns of Vascular Supply Within Lymphoepithelial Mucosa in Oropharyngeal Cancer
Conditions: Oropharyngeal Carcinoma;   Oropharynx Cancer
20 Recruiting A Pilot Study at a Single-Institution of Pregabalin in the Management of Mucositis Pain in Patients Undergoing Chemoradiation Therapy to the Head and Neck.
Conditions: Oropharyngeal Cancer;   Squamous Cell Carcinoma to the Head and Neck
Intervention: Drug: Lyrica 300 mg

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years